from Today's Healthcare News -- ScienceDaily http://ift.tt/1FzD4ZD
Our mission is to advice, and to make the people of the world healthier through the power of information.
Immune system marker for therapy-resistant prostate cancer
A research team shows how signaling by an immune system component called interleukin-6 (IL-6) appears to play an important role in driving aggressive, therapy-resistant prostate cancer.
from Today's Healthcare News -- ScienceDaily http://ift.tt/1FzD4ZD
from Today's Healthcare News -- ScienceDaily http://ift.tt/1FzD4ZD
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment